Sign in

CIK 0001341235 · Non-accelerated filer<br>Smaller reporting company

Aldeyra Therapeutics, Inc.

Sign in to watch
Ticker
ALDX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
781-761-4904
Business address
23 BRADFORD STREET, SUITE 1, CONCORD, MA, 01742
Former names
Aldexa Therapeutics, Inc., Neuron Systems Inc
  1. 8-K Event Results of operations
  2. 4 Grant or award President and CEO acquired 101,269 shares (grant or award)
  3. 4 Grant or award Chief Medical Officer acquired 4,774 shares (grant or award)
  4. 4 Grant or award Chief Financial Officer acquired 5,230 shares (grant or award)
  5. 8-K Event Other events
  6. SC 13G/A Stake Amended Statement of Ownership
  7. SC 13G/A Stake Amended Statement of Ownership
  8. SC 13G Stake Amended Statement of Ownership
  9. 8-K Event Material agreement
  10. 10-Q Report Quarterly Report
  11. 8-K Event Results of operations
  12. SC 13G/A Stake Amended Statement of Ownership
  13. 8-K Event Regulation FD disclosure · Other events
  14. 8-K Event Other events
  15. 4 Open-market buy 10% owner bought 200,000 shares at $7.25 ($1,450,000)
  16. 424B5 Offering Prospectus
  17. 8-K Event Material agreement · Other events
  18. 424B5 Offering Prospectus
  19. 8-K Event Other events
  20. 8-K Event Material agreement · Regulation FD disclosure · Other events

Page 21 of 33 · 650 filings